# Eplerenone

## Inspra F.C. 50mg

| TAH Drug Code      | [OINS](https://www.tahsda.org.tw/drugs/hissearch.php?drug_code=OINS)                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                         |
|:-------------------|:---------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|
| Indications        | General Dosage Information Heart failure， Symptomatic， with reduced ejection fraction (40% or less) - Myocardial infarction Hypertension Primary aldosteronism Systolic heart failure (Mild) NYHA Class 2 of Heart Failure                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                 |
| Dosing             | Heart failure - Myocardial infarction with complication: initial， 25 mg once daily; titration preferably within 4 weeks to 50 mg once daily. Hypertension: initial， 50 mg once daily; allow 4 weeks to achieve optimum antihypertensive effect; may increase to maximum 50 mg twice daily for inadequate response. New York Heart Association class II (chronic) heart failure: initial， 25 mg once daily， followed by an increase to 50 mg once daily after 4 weeks if potassium level no more than 5 mmol/L.                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                           |
| Hepatic Impairment | Dose adjustment required                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                     |
| Renal Impairment   | Dose adjustment required                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                     |
| Contraindications  | [仿單] For All Patients with hypersensitivity to eplerenone， serum potassium >5.0 mEq/L at initiation， creatinine clearance <=30 mL/min， severe hepatic insufficiency (Child-Pugh class C)， concomitant administration of strong CYP3A4 inhibitors or potassium-sparing diuretics， or concomitant administration of angiotensin-converting enzyme inhibitors(ACEI) or angiotensin receptor blockers(ARB). For the treatment of hypertension in patients with type 2 diabetes with microalbuminuria， serum creatinine >2.0 mg/dL in males or >1.8 mg/dL in females， creatinine clearance <50 mL/min， or concomitant administration of potassium supplements. [Micromedex] (All patients) Serum potassium greater than 5.5 mEq/L at initiation. (All patients) Creatinine clearance 30 mL/min or less. (All patients) Concomitant administration of strong CYP3A inhibitors. (Hypertension patients) Type 2 diabetes with microalbuminuria. (Hypertension patients) Serum creatinine greater than 2 mg/dL in males or greater than 1.8 mg/dL in females. (Hypertension patients) Creatinine clearance less than 50 mL/min. (Hypertension patients) Concomitant administration of potassium supplements or potassium-sparing diuretics. |
| Adverse Effects    | ommon Endocrine metabolic: Hyperkalemia (3.4% ) Renal: Serum creatinine raised (2.4% ) Serious Cardiovascular: Angina pectoris， Myocardial infarction                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                       |
| Pregnancy          | Unknown                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                      |
| Lactation          | Unknown                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                      |
| More Info          | [UpToDate](https://www.uptodate.com/contents/eplerenone-drug-information)                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                    |

